Literature DB >> 8906374

Miller Fisher syndrome in infancy.

J Benito-León1, J Bravo, F Mateos, R Simón.   

Abstract

Miller Fisher syndrome (MFS) is characterized by the triad of ataxia, areflexia and ophthalmoplegia. It is exceptional for infants to be involved. Two infants, aged 11 and 16 months, developed acute-onset MFS. Both patients had prodromal upper respiratory tract infection. Pupillary responses to light, strength and sensation modalities were preserved. One patient was lethargic for a day; the electroencephalogram disclosed slightly slow background activity that later became normal. The other received high-dose intravenous immunoglobulins for 5 consecutive days starting at once on admission; within the next 7 days he became asymptomatic. Increased cerebrospinal fluid protein content and delayed nerve conduction studies with prolonged distal latencies were encountered in both patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906374     DOI: 10.1007/bf00261612

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  12 in total

1.  An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia).

Authors:  M FISHER
Journal:  N Engl J Med       Date:  1956-07-12       Impact factor: 91.245

Review 2.  Manipulating the immune system with immune globulin.

Authors:  J M Dwyer
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

3.  Polyradiculitis (Landry-Guillain-Barré syndrome) with total external ophthalmoplegia: encephalo-myelo-radiculo-neuropathy.

Authors:  S H Green
Journal:  Dev Med Child Neurol       Date:  1976-06       Impact factor: 5.449

4.  Miller-Fisher syndrome in a 22-month-old child.

Authors:  B Y Qaqundah; W F Taylor
Journal:  J Pediatr       Date:  1970-11       Impact factor: 4.406

5.  High dose immunoglobulin therapy is effective in the Miller Fisher syndrome.

Authors:  U Zifko; M Drlicek; G Senautka; W Grisold
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

6.  Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release.

Authors:  M Roberts; H Willison; A Vincent; J Newsom-Davis
Journal:  Lancet       Date:  1994-02-19       Impact factor: 79.321

Review 7.  Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review.

Authors:  S N al-Din; M Anderson; O Eeg-Olofsson; J V Trontelj
Journal:  Acta Neurol Scand       Date:  1994-03       Impact factor: 3.209

8.  Fisher syndrome in childhood.

Authors:  W J Becker; G V Watters; P Humphreys
Journal:  Neurology       Date:  1981-05       Impact factor: 9.910

9.  The use of intravenous immunoglobulin in Miller Fisher syndrome.

Authors:  Y Arakawa; M Yoshimura; S Kobayashi; K Ichihashi; M Miyao; M Y Momoi; M Yanagisawa
Journal:  Brain Dev       Date:  1993 May-Jun       Impact factor: 1.961

10.  Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.

Authors:  H J Willison; J Veitch; G Paterson; P G Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.